| Bioactivity | ALC-0159, a polyethylene glycol (PEG) lipid conjugate, could be used as vaccine excipient[1]. | ||||||||||||
| Invitro | ALC-0159, which contributes to nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety[1]. | ||||||||||||
| Name | ALC-0159 | ||||||||||||
| CAS | 1849616-42-7 | ||||||||||||
| Formula | (C2H4O)nC31H63NO2 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. S Moein Moghimi, et al. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021 Mar 3;29(3):898-900. |